Blueshift Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,457	Closed	-$294K	–	406
2024 Q3	$294K	Buy	+4,457	New	+$324K	0.07%	283
2023 Q4	–	Sell	-3,289	Closed	-$228K	–	294
2023 Q3	$228K	Buy	+3,289	New	+$264K	0.13%	231
2023 Q2	–	Sell	-2,567	Closed	-$212K	–	390
2023 Q1	$212K	Buy	+2,567	New	+$202K	0.09%	294
2022 Q4	–	Sell	-5,086	Closed	-$420K	–	437
2022 Q3	$420K	Buy	+5,086	New	+$489K	0.09%	320
2021 Q3	–	Sell	-2,642	Closed	-$274K	–	1081
2021 Q2	$274K	Buy	+2,642	New	+$249K	0.02%	755
2021 Q1	–	Sell	-33,257	Closed	-$3.03M	–	914
2020 Q4	$3.03M	Buy	+33,257	New	+$2.76M	0.36%	65
2019 Q2	–	Sell	-7,176	Closed	-$458K	–	775
2019 Q1	$458K	Sell	7,176 -19,314	-73%	-$1.1M	0.06%	419
2018 Q4	$1.35M	Buy	+26,490	New	+$1.34M	0.25%	94